
|Slideshows|November 28, 2017
Toward Biomarker-Guided Treatment in Psychosis
Author(s)Brian Miller, MD, PhD, MPH
Is oxidative stress a therapeutic target in schizophrenia?
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
2
Accident, or Is It? The Watershed Area Between Trauma and Suicide
3
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
4
The Bind of the Binary: Psychiatry’s Critics and the Law of the Excluded Middle
5

















